244 related articles for article (PubMed ID: 10855786)
1. Role of an anti-epidermal growth factor receptor in treating cancer.
Waksal HW
Cancer Metastasis Rev; 1999; 18(4):427-36. PubMed ID: 10855786
[TBL] [Abstract][Full Text] [Related]
2. The role of cetuximab in the treatment of squamous cell cancer of the head and neck.
Burtness B
Expert Opin Biol Ther; 2005 Aug; 5(8):1085-93. PubMed ID: 16050785
[TBL] [Abstract][Full Text] [Related]
3. Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody.
Harding J; Burtness B
Drugs Today (Barc); 2005 Feb; 41(2):107-27. PubMed ID: 15821783
[TBL] [Abstract][Full Text] [Related]
4. IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody, for treatment of head and neck cancer.
Herbst RS; Kim ES; Harari PM
Expert Opin Biol Ther; 2001 Jul; 1(4):719-32. PubMed ID: 11727507
[TBL] [Abstract][Full Text] [Related]
5. [Epidermal growth factor receptors (EGFR): a new target for anticancer therapy].
Gainet M; Guardiola E; Dufresne A; Pivot X
Cancer Radiother; 2003 Jun; 7(3):195-9. PubMed ID: 12834777
[TBL] [Abstract][Full Text] [Related]
6. [Anti-EGFR therapy: towards a "à la carte" targeting of hepatocellular carcinoma].
Fartoux L; Desbois-Mouthon C; Poupon R; Rosmorduc O
Gastroenterol Clin Biol; 2006 Oct; 30(10):1133-5. PubMed ID: 17075466
[No Abstract] [Full Text] [Related]
7. Cetuximab: from bench to bedside.
Vincenzi B; Zoccoli A; Pantano F; Venditti O; Galluzzo S
Curr Cancer Drug Targets; 2010 Feb; 10(1):80-95. PubMed ID: 20088790
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor biology (IMC-C225).
Kim ES; Khuri FR; Herbst RS
Curr Opin Oncol; 2001 Nov; 13(6):506-13. PubMed ID: 11673692
[TBL] [Abstract][Full Text] [Related]
9. Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotide.
Ciardiello F; Caputo R; Bianco R; Damiano V; Pomatico G; Pepe S; Bianco AR; Agrawal S; Mendelsohn J; Tortora G
J Natl Cancer Inst; 1998 Jul; 90(14):1087-94. PubMed ID: 9672257
[TBL] [Abstract][Full Text] [Related]
10. Anti-epidermal growth factor receptor drugs in cancer therapy.
Ciardiello F; Tortora G
Expert Opin Investig Drugs; 2002 Jun; 11(6):755-68. PubMed ID: 12036420
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological background of EGFR targeting.
Castillo L; Etienne-Grimaldi MC; Fischel JL; Formento P; Magné N; Milano G
Ann Oncol; 2004 Jul; 15(7):1007-12. PubMed ID: 15205192
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor (EGFR) inhibitors in cancer therapy.
Ciardiello F; De Vita F
Prog Drug Res; 2005; 63():93-114. PubMed ID: 16265878
[No Abstract] [Full Text] [Related]
13. Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiation.
Harari PM; Huang SM
Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):427-33. PubMed ID: 11173137
[TBL] [Abstract][Full Text] [Related]
14. Epithelial growth factor receptor interacting agents.
Baselga J; Albanell J
Hematol Oncol Clin North Am; 2002 Oct; 16(5):1041-63. PubMed ID: 12512382
[TBL] [Abstract][Full Text] [Related]
15. IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody for treatment of head and neck cancer.
Herbst RS; Hong WK
Semin Oncol; 2002 Oct; 29(5 Suppl 14):18-30. PubMed ID: 12422310
[TBL] [Abstract][Full Text] [Related]
16. Radiation response modification following molecular inhibition of epidermal growth factor receptor signaling.
Harari PM; Huang SM
Semin Radiat Oncol; 2001 Oct; 11(4):281-9. PubMed ID: 11677653
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with monoclonal antibodies to epidermal growth factor receptor.
Calvo E; Rowinsky EK
Curr Oncol Rep; 2005 Mar; 7(2):96-103. PubMed ID: 15717942
[TBL] [Abstract][Full Text] [Related]
18. Why the epidermal growth factor receptor? The rationale for cancer therapy.
Baselga J
Oncologist; 2002; 7 Suppl 4():2-8. PubMed ID: 12202782
[TBL] [Abstract][Full Text] [Related]
19. Anti-epidermal growth factor receptor antibodies in the treatment of metastatic colorectal cancer.
Lee D
Clin Colorectal Cancer; 2004 Sep; 4(3):159-62. PubMed ID: 15377399
[No Abstract] [Full Text] [Related]
20. The EGFR as a target for anticancer therapy--focus on cetuximab.
Baselga J
Eur J Cancer; 2001 Sep; 37 Suppl 4():S16-22. PubMed ID: 11597400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]